Abstract: There is disclosed systems and methods for non-invasive delivery of an agent to biological tissues. Delivery of the agent to the tissues can be by one or more modalities. In some embodiments the systems and methods use agent carrier body including a tissue contacting surface for non-invasively engaging tissues under treatment. The tissue contacting surface can be at least partly defined by a plurality of protrusions that are in fluid communication with one or more reservoirs forming part of the agent carrier body. The protrusions may extend outward from an inside of a void and terminate at said tissue contacting surface.
Type:
Grant
Filed:
May 30, 2024
Date of Patent:
January 13, 2026
Assignee:
MuPharma Pty Ltd
Inventors:
Harry Unger, Mark Unger, Sean Michael Langelier
Abstract: There is disclosed systems and methods for non-invasive delivery of an agent to biological tissues. Delivery of the agent to the tissues can be by one or more modalities. In some embodiments the systems and methods use agent carrier body including a tissue contacting surface for non-invasively engaging tissues under treatment. The tissue contacting surface can be at least partly defined by a plurality of protrusions that are in fluid communication with one or more reservoirs forming part of the agent carrier body. The protrusions may extend outward from an inside of a void and terminate at said tissue contacting surface.
Type:
Grant
Filed:
April 29, 2021
Date of Patent:
October 15, 2024
Assignee:
MuPharma Pty Ltd
Inventors:
Harry Unger, Mark Unger, Sean Michael Langelier
Abstract: There is disclosed systems and methods for non-invasive delivery of an agent to biological tissues. Delivery of the agent to the tissues can be by one or more modalities. In some embodiments the systems and methods use agent carrier body including a tissue contacting surface for non-invasively engaging tissues under treatment. The tissue contacting surface can be at least partly defined by a plurality of protrusions that are in fluid communication with one or more reservoirs forming part of the agent carrier body. The protrusions may extend outward from an inside of a void and terminate at said tissue contacting surface.
Type:
Grant
Filed:
July 27, 2020
Date of Patent:
July 9, 2024
Assignee:
MuPharma Pty Ltd
Inventors:
Harry Unger, Sean Michael Langelier, Mark Unger
Abstract: An agent carrier delivers an agent to biological tissues by one or more modalities. The modality of delivery may be one or more transportation stimulus that causes the agent to be transported through the agent carrier. The transportation stimulus also enhances or permits penetration of the agent into the tissue. The agent carrier has an agent carrier body that is configured to retain the agent within the agent carrier body. The agent carrier body has a tissue-contacting surface for engaging tissues under treatment. Application of the transportation stimulus causes transportation of the agent through the agent carrier body to the tissue-contacting surface.
Type:
Application
Filed:
May 6, 2014
Publication date:
April 14, 2016
Applicant:
MuPharma Pty Ltd
Inventors:
Harry Unger, Sean Michael Langelier, Mark Unger